Free Trial

Bausch Health Companies (BHC) Competitors

Bausch Health Companies logo
C$10.06 +0.02 (+0.20%)
As of 09/12/2025 04:00 PM Eastern

BHC vs. APHA, PBH, AUP, TLRY, CARA, CRON, SLS, TEV, ABT, and NOT

Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Aurinia Pharmaceuticals (AUP), Tilray Brands (TLRY), Cara Operations (CARA), Cronos Group (CRON), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), and Noront Resources (NOT). These companies are all part of the "pharmaceutical products" industry.

Bausch Health Companies vs. Its Competitors

Aphria (TSE:APHA) and Bausch Health Companies (TSE:BHC) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

In the previous week, Bausch Health Companies had 2 more articles in the media than Aphria. MarketBeat recorded 2 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 0.34 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company Overall Sentiment
Aphria Neutral
Bausch Health Companies Neutral

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -1.88%. Bausch Health Companies' return on equity of 15.87% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Bausch Health Companies -1.88%15.87%4.16%

Given Aphria's higher probable upside, research analysts clearly believe Aphria is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bausch Health Companies has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Bausch Health CompaniesC$9.86B0.38-C$125.65MC$0.2638.69

8.7% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Bausch Health Companies beats Aphria on 11 of the 13 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHC vs. The Competition

MetricBausch Health CompaniesDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$3.72BC$1.67BC$5.82BC$9.44B
Dividend Yield0.76%2.93%5.68%6.50%
P/E Ratio38.6966.9375.4125.78
Price / Sales0.381,297.60514.809.35
Price / Cash7.7610.3737.5683.29
Price / Book-15.3111.9112.155.54
Net Income-C$125.65MC$20.70BC$3.29BC$301.20M
7 Day Performance-1.18%0.60%0.74%1.43%
1 Month Performance-3.08%1.42%5.00%8.13%
1 Year Performance16.98%5.00%62.55%36.77%

Bausch Health Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHC
Bausch Health Companies
N/AC$10.06
+0.2%
N/A+17.0%C$3.72BC$9.86B38.6919,900News Coverage
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06M-8.231,200
PBH
Premium Brands
2.8401 of 5 stars
C$94.46
+0.8%
C$111.18
+17.7%
+2.5%C$4.22BC$6.90B45.41540
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
TLRY
Tilray Brands
N/AC$1.89
-6.4%
N/A-34.2%C$2.08BC$821.31M-0.772,650Gap Up
High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
CRON
Cronos Group
N/AC$3.56
-0.3%
N/A+17.9%C$1.36BC$130.28M71.20450
SLS
Solaris Resources
1.8297 of 5 stars
C$7.56
-1.0%
C$12.50
+65.3%
+135.8%C$1.25BN/A-18.4410News Coverage
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700

Related Companies and Tools


This page (TSE:BHC) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners